Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Belite Bio, Inc (BLTE)

26.05   -1.43 (-5.2%) 08-19 01:56
Open: 27 Pre. Close: 27.48
High: 28.5 Low: 25.125
Volume: 71,642 Market Cap: 648(M)
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 30.72 - 30.91 30.91 - 31.04
Low: 26.63 - 26.84 26.84 - 27
Close: 26.88 - 27.19 27.19 - 27.42

Technical analysis

as of: 2022-08-18 3:51:13 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 43.42     One year: 52.12
Support: Support1: 25.12    Support2: 20.9
Resistance: Resistance1: 37.17    Resistance2: 44.63
Pivot: 30.1
Moving Average: MA(5): 28.54     MA(20): 31.86
MA(100): 0     MA(250): 0
MACD: MACD(12,26): -1.9     Signal(9): -1.3
Stochastic oscillator: %K(14,3): 8.1     %D(3): 11.7
RSI: RSI(14): 37.8
52-week: High: 44.7  Low: 8.8
Average Vol(K): 3-Month: 87 (K)  10-Days: 56 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BLTE ] has closed above bottom band by 6.0%. Bollinger Bands are 0% narrower than normal.

Headline News

Tue, 16 Aug 2022
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 9.2% in July - MarketBeat

Sun, 14 Aug 2022
Belite Bio (NASDAQ:BLTE) Stock Price Down 3.8% - Defense World

Sat, 13 Aug 2022
Belite Bio, Inc's (BLTE) CEO Tom Lin on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Wed, 10 Aug 2022
Is Belite Bio Inc (BLTE) Stock About to Get Hot Wednesday? - InvestorsObserver

Wed, 03 Aug 2022
Belite Bio (NASDAQ:BLTE) Coverage Initiated by Analysts at HC Wainwright - Defense World

Mon, 01 Aug 2022
Belite Bio (NASDAQ:BLTE) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 24 (M)
Shares Float 3 (M)
% Held by Insiders 72.4 (%)
% Held by Institutions 0 (%)
Shares Short 111 (K)
Shares Short P.Month 26 (K)

Stock Financials

EPS -1.01
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.48
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -27.8
Return on Equity (ttm) -46.6
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.41
Qtrly Earnings Growth 0
Operating Cash Flow -7 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -26.18
PEG Ratio 0
Price to Book value -17.99
Price to Sales 0
Price to Cash Flow -85.31

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.